We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-8.89%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$513M
AUM Growth
-$457M
Cap. Flow
-$450M
Cap. Flow %
-87.61%
Top 10 Hldgs %
17.54%
Holding
218
New
19
Increased
57
Reduced
54
Closed
46

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$6.06M
2
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$5.46M
3
ESTC icon
Elastic
ESTC
+$4.52M
4
KRNT icon
Kornit Digital
KRNT
+$3.77M
5
AXSM icon
Axsome Therapeutics
AXSM
+$3.61M

Top Sells

Rank Stock Value
1
LVS icon
Las Vegas Sands
LVS
+$69M
2
MLCO icon
Melco Resorts & Entertainment
MLCO
+$52M
3
KTB icon
Kontoor Brands
KTB
+$17.6M
4
CZR
Caesars Entertainment Corporation
CZR
+$13.6M
5
PZZA icon
Papa John's
PZZA
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 23.77%
2 Technology 17.55%
3 Consumer Discretionary 8.35%
4 Industrials 6.82%
5 Consumer Staples 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGOP
26
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
– –
0
– –
FTDR icon
27
Frontdoor
FTDR
$6.26B
$4.16M 0.81%
119,603
+2,041
+2% +$86.9K
PEN icon
28
Penumbra
PEN
$12.8B
$4.11M 0.8%
25,460
-4,957
-16% -$835K
DCPH
29
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4.05M 0.79%
+98,299
New +$5.46M
FRC
30
DELISTED
First Republic Bank
FRC
$3.96M 0.77%
48,105
-101,758
-68% -$10.8M
GBT
31
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.91M 0.76%
76,596
+9,281
+14% +$622K
BURL icon
32
Burlington
BURL
$23.2B
$3.86M 0.75%
24,362
+3,431
+16% +$722K
GPN icon
33
Global Payments
GPN
$22.8B
$3.8M 0.74%
26,356
+13,083
+99% +$2.39M
AMZN icon
34
Amazon
AMZN
$2.96T
$3.79M 0.74%
38,860
+11,640
+43% +$1.13M
RNG icon
35
RingCentral
RNG
$5.28B
$3.66M 0.71%
17,289
+14,401
+499% +$2.97M
WAL icon
36
Western Alliance Bancorporation
WAL
$8.87B
$3.64M 0.71%
119,012
-9,483
-7% -$453K
PLMR icon
37
Palomar
PLMR
$3.45B
$3.63M 0.71%
+62,358
New +$3.26M
LVGO
38
DELISTED
Livongo Health, Inc. Common Stock
LVGO
$3.62M 0.71%
126,980
+27,828
+28% +$721K
KRYS icon
39
Krystal Biotech
KRYS
$9.66B
$3.54M 0.69%
81,916
+7,498
+10% +$392K
EW icon
40
Edwards Lifesciences
EW
$51.7B
$3.52M 0.69%
56,061
-2,589
-4% -$187K
TWST icon
41
Twist Bioscience
TWST
$7.25B
$3.49M 0.68%
+114,172
New +$3.07M
MSFT icon
42
Microsoft
MSFT
$3.71T
$3.48M 0.68%
22,047
-12,445
-36% -$2.05M
SRPT icon
43
Sarepta Therapeutics
SRPT
$1.77B
$3.42M 0.67%
34,963
-753
-2% -$86.1K
TPTX
44
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$3.37M 0.66%
75,487
-4,955
-6% -$263K
NVDA icon
45
NVIDIA
NVDA
$5.42T
$3.34M 0.65%
507,440
+195,000
+62% +$1.23M
AXSM icon
46
Axsome Therapeutics
AXSM
$10.9B
$3.34M 0.65%
56,801
+44,358
+356% +$3.61M
IMMU
47
DELISTED
Immunomedics Inc
IMMU
$3.31M 0.65%
245,822
+12,177
+5% +$205K
SILK
48
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$3.27M 0.64%
103,882
-16,825
-14% -$674K
GPK icon
49
Graphic Packaging
GPK
$3.58B
$3.27M 0.64%
267,743
+1,839
+0.7% +$27.1K
LRCX icon
50
Lam Research
LRCX
$390B
$3.25M 0.63%
135,620
+5,910
+5% +$170K
1
2
3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Nicholas Investment Partners held 218 positions worth $513M, down 47% from $971M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $450M in Q1 2020, closing 46 positions and reducing 54 holdings. Its most notable exit was Las Vegas Sands, an estimated $69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Nicholas Investment Partners opened a new position in Deciphera Pharmaceuticals, Inc. Common Stock worth $4.05M.

  • Nicholas Investment Partners's largest Q1 2020 buy was Deciphera Pharmaceuticals, Inc. Common Stock: 98,299 shares worth $4.05M.
  • Nicholas Investment Partners added most to Freshpet in Q1 2020, an estimated $6.06M increase.
  • Nicholas Investment Partners's biggest Q1 2020 reduction was Kontoor Brands, cutting an estimated $17.6M.
  • Nicholas Investment Partners fully exited Las Vegas Sands in Q1 2020, selling an estimated $69M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $513M portfolio in Q1 2020.
  • Nicholas Investment Partners opened 19 new positions and closed 46 in Q1 2020.
  • Nicholas Investment Partners's portfolio value fell 47% quarter-over-quarter to $513M.

Based on Nicholas Investment Partners's 13F filing for Q1 2020, filed 13 May 2020.